FDA says it's not against compounding

The Food & Drug Administration most emphatically is not against compounding of drugs, Steven Silverman, a key enforcement officer in that agency, told the National Association of Boards of Pharmacy recently.

Asserting that the kinds of compounding the agency brings enforcement actions against are "outliers," operations that really don't come under the rubric of traditional compounding, Silverman said, "There has been a certain amount of hysteria generated by a select few organizations" that the agency's objective is to end compounding.

View Full Article